Gulf Coast Blood Center Enhances Operations With HemoFlow 500 And Cloud Analytics

Applied Science, a global leader in whole blood collection products and services, has announced that Gulf Coast Regional Blood Center has acquired its next-generation device, the HemoFlow 500, along with HemoVue, a cloud-based service. This service works with HemoFlow devices to provide real-time operational data and analytics, enhancing blood collection processes.

Gulf Coast Regional Blood Center, a nonprofit accredited by the Food and Drug Administration, supplies blood and blood components to over 170 hospitals and healthcare facilities across a 26-county region in Texas. The center is upgrading its fleet of older HemoFlow 400 devices with 100 new HemoFlow 500xs devices. These new devices offer advanced software features for configuring and managing a mixed fleet of devices.

"Unlike other device providers, Applied Science has recognized the value to blood banks of maintaining compatibility across a mixed fleet of devices and made it easy to do," said Ral Trujillo, Vice President of Sales, Marketing, and Customer Success at Applied Science. This approach allows customers to replace older devices as needed, avoiding large capital outlays while benefiting from the latest technology.

Marc Lewis, VP of Operations at Gulf Coast Regional Blood Center, praised the HemoFlow 500 for its user-friendly interface and programmable features. "The scale's user-friendly interface and programmable features ensure consistent and repeatable results, simplifying the whole blood collection process," he said. The device is noted for its durability and accuracy.

The HemoFlow 500 series devices are the lightest in the industry at just 3.5 lbs. They feature a battery life that supports up to 230 draws per charge, outperforming other blood mixer and scale devices on the market. Advanced features include a large touch-screen display, integrated barcode scanner, onboard collection record storage, and wireless connectivity.

These features streamline the donation process by maximizing collection efficiency and providing a paperless, automated whole blood collection system. The system eliminates manual data entry errors, reduces waste, enhances profitability, and allows phlebotomists to focus on donor care.

Jonathan Morgan, President and CEO of Applied Science, emphasized the benefits of increased automation in blood banks. "By increasing blood bank automation, we are helping our customers improve efficiency, reduce errors, and better manage inventory and donations," he said. The company aims to make healthcare delivery easier and more efficient through workflow automation and data integration.

Applied Science provides workflow automation and data integration platforms for transfusion medicine and chronic care management. Through its HemoFlow brand, Applied Science offers solutions globally to organizations such as the American Red Cross and the UK's National Health Service. The company empowers health systems to manage outcomes remotely for patients with chronic conditions using advanced devices, services, informatics, and data tools.

For more information about Applied Science's products and services, visit their website at applied-science.com.